| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.55B | -15.3% |
| R&D Expense | $39.0M | +21.9% |
| SG&A Expense | $226.0M | +10.8% |
| Interest Expense | $107.0M | +0.9% |
| Pre-tax Income | -$584.0M | -183.2% |
| Income Tax | $189.0M | -71.5% |
| Net Income | -$651.0M | -429.3% |
| EPS (Basic) | -$3.65 | -436.8% |
| EPS (Diluted) | -$3.65 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $944.0M | -30.7% |
| Accounts Receivable | $656.0M | -15.7% |
| Inventory | $2.16B | -11.1% |
| Current Assets | $4.41B | -16.1% |
| Total Assets | $14.15B | -4.1% |
| Current Liabilities | $3.03B | +0.9% |
| Long-term Debt | $1.81B | +0.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $91.0M | -88.9% |
| Capital Expenditures | $531.0M | +10.6% |
| Investing Cash Flow | -$585.0M | -18.2% |
| Financing Cash Flow | $57.0M | +107.4% |
| Free Cash Flow | -$440.0M | -228.7% |
| -436.8% |
| Total Liabilities |
| $8.31B |
| +1.8% |
| Stockholders' Equity | $4.25B | -16.3% |